참고문헌
- Brooks GF, Jawetz E, Melnick JL, Adelberg EA. Jawetz, Melnick and Adelberg's medical microbiology. New York: Mc-Graw Hill Medical; 2010.
- Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. St. Louis, MO: Mosby; 2002. p.429-41.
- Murphy BP, Murphy M, Buckley JF, et al. In-line milk filter analysis: Escherichia coli O157 surveillance of milk production holdings. Int J Hyg Environ Health 2005;208:407-13. https://doi.org/10.1016/j.ijheh.2005.03.001
- Blanco JE, Blanco M, Alonso MP, et al. Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999. J Clin Microbiol 2004;42:311-9. https://doi.org/10.1128/JCM.42.1.311-319.2004
- te Loo DM, Monnens LA, van Der Velden TJ, et al. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 2000;95:3396-402.
- Chaisri U, Nagata M, Kurazono H, et al. Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome. Microb Pathog 2001;31:59-67. https://doi.org/10.1006/mpat.2001.0447
- Kuhne SA, Hawes WS, La Ragione RM, Woodward MJ, Whitelam GC, Gough KC. Isolation of recombinant antibodies against EspA and intimin of Escherichia coli O157:H7. J Clin Microbiol 2004;42:2966-76. https://doi.org/10.1128/JCM.42.7.2966-2976.2004
- Sussman M. Escherichia coli: mechanisms of virulence. New York: Cambridge University Press; 1997.
- van Diemen PM, Dziva F, Abu-Median A, et al. Subunit vaccines based on intimin and Efa-1 polypeptides induce humoral immunity in cattle but do not protect against intestinal colonisation by enterohaemorrhagic Escherichia coli O157:H7 or O26:H. Vet Immunol Immunopathol 2007; 116:47-58. https://doi.org/10.1016/j.vetimm.2006.12.009
- Ghaem-Maghami M, Simmons CP, Daniell S, et al. Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium. Infect Immun 2001;69:5597-605. https://doi.org/10.1128/IAI.69.9.5597-5605.2001
- Wales AD, Woodward MJ, Pearson GR. Attaching-effacing bacteria in animals. J Comp Pathol 2005;132:1-26. https://doi.org/10.1016/j.jcpa.2004.09.005
- Bertin Y, Boukhors K, Livrelli V, Martin C. Localization of the insertion site and pathotype determination of the locus of enterocyte effacement of shiga toxin-producing Escherichia coli strains. Appl Environ Microbiol 2004;70:61-8. https://doi.org/10.1128/AEM.70.1.61-68.2004
- Donnenberg MS, Whittam TS. Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coli. J Clin Invest 2001;107:539-48. https://doi.org/10.1172/JCI12404
- Thapar N, Sanderson IR. Diarrhoea in children: an interface between developing and developed countries. Lancet 2004;363:641-53. https://doi.org/10.1016/S0140-6736(04)15599-2
- Krause G, Zimmermann S, Beutin L. Investigation of domestic animals and pets as a reservoir for intimin- (eae) gene positive Escherichia coli types. Vet Microbiol 2005; 106:87-95. https://doi.org/10.1016/j.vetmic.2004.11.012
- Adu-Bobie J, Frankel G, Bain C, et al. Detection of intimins alpha, beta, gamma, and delta, four intimin derivatives expressed by attaching and effacing microbial pathogens. J Clin Microbiol 1998;36:662-8.
- Svennerholm AM. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res 2011;133:188-96.
- Fujkuyama Y, Tokuhara D, Kataoka K, et al. Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 2012;11:367-79. https://doi.org/10.1586/erv.11.196
- Woodrow KA, Bennett KM, Lo DD. Mucosal vaccine design and delivery. Annu Rev Biomed Eng 2012;14:17-46. https://doi.org/10.1146/annurev-bioeng-071811-150054
- Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002;6:319-27. https://doi.org/10.1016/S1359-0286(02)00117-1
- Cho EJ, Holback H, Liu KC, Abouelmagd SA, Park J, Yeo Y. Nanoparticle characterization: state of the art, challenges, and emerging technologies. Mol Pharm 2013;10:2093-110. https://doi.org/10.1021/mp300697h
- Bollag DM, Rozycki MD, Edelstein SJ. Protein methods. 2nd ed. New York: Wiley-Liss; 1996.
- Aslani MM, Bouzari S. An epidemiological study on Verotoxin-producing Escherichia coli (VTEC) infection among population of northern region of Iran (Mazandaran and Golestan provinces). Eur J Epidemiol 2003;18:345-9.
- Potter AA, Klashinsky S, Li Y, et al. Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine 2004;22:362-9. https://doi.org/10.1016/j.vaccine.2003.08.007
- Walker CL, Aryee MJ, Boschi-Pinto C, Black RE. Estimating diarrhea mortality among young children in low and middle income countries. PLoS One 2012;7:e29151. https://doi.org/10.1371/journal.pone.0029151
- Shariati Mehr K, Mousavi SL, Rasooli I, Amani J, Rajabi M. A DNA vaccine against Escherichia coli O157:H7. Iran Biomed J 2012;16:133-9.
- van Diemen PM, Dziva F, Stevens MP, Wallis TS. Identification of enterohemorrhagic Escherichia coli O26:H- genes required for intestinal colonization in calves. Infect Immun 2005;73:1735-43. https://doi.org/10.1128/IAI.73.3.1735-1743.2005
- Dziva F, van Diemen PM, Stevens MP, Smith AJ, Wallis TS. Identification of Escherichia coli O157 : H7 genes influencing colonization of the bovine gastrointestinal tract using signature-tagged mutagenesis. Microbiology 2004;150(Pt 11): 3631-45. https://doi.org/10.1099/mic.0.27448-0
- Cornick NA, Booher SL, Moon HW. Intimin facilitates colonization by Escherichia coli O157:H7 in adult ruminants. Infect Immun 2002;70:2704-7. https://doi.org/10.1128/IAI.70.5.2704-2707.2002
- Dean-Nystrom EA, Bosworth BT, Moon HW, O'Brien AD. Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves. Infect Immun 1998;66:4560-3.
- Dean-Nystrom EA, Bosworth BT, Moon HW. Pathogenesis of Escherichia coli O157:H7 in weaned calves. Adv Exp Med Biol 1999;473:173-7.
- Paton AW, Manning PA, Woodrow MC, Paton JC. Translocated intimin receptors (Tir) of Shiga-toxigenic Escherichia coli isolates belonging to serogroups O26, O111, and O157 react with sera from patients with hemolytic-uremic syndrome and exhibit marked sequence heterogeneity. Infect Immun 1998;66:5580-6.
- Li Y, Frey E, Mackenzie AM, Finlay BB. Human response to Escherichia coli O157:H7 infection: antibodies to secreted virulence factors. Infect Immun 2000;68:5090-5. https://doi.org/10.1128/IAI.68.9.5090-5095.2000
- McNeilly TN, Mitchell MC, Corbishley A, et al. Optimizing the protection of cattle against Escherichia coli O157:H7 colonization through immunization with different combinations of H7 flagellin, Tir, Intimin-531 or EspA. PLoS One 2015;10:e0128391. https://doi.org/10.1371/journal.pone.0128391
- Amani J, Salmanian AH, Rafati S, Mousavi SL. Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7. Vaccine 2010;28: 6923-9. https://doi.org/10.1016/j.vaccine.2010.07.061
- Amani J, Mousavi SL, Rafati S, Salmanian AH. Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice. Plant Sci 2011; 180:620-7. https://doi.org/10.1016/j.plantsci.2011.01.004
- Rabinovitz BC, Larzabal M, Vilte DA, Cataldi A, Mercado EC. The intranasal vaccination of pregnant dams with Intimin and EspB confers protection in neonatal mice from Escherichia coli (EHEC) O157:H7 infection. Vaccine 2016; 34:2793-7. https://doi.org/10.1016/j.vaccine.2016.04.056
- Chen W, Zhang B, Mahony T, Gu W, Rolfe B, Xu ZP. Efficient and durable vaccine against intimin beta of diarrheagenic E. coli induced by clay nanoparticles. Small 2016; 12:1627-39. https://doi.org/10.1002/smll.201503359
- Carroll EC, Jin L, Mori A, et al. The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGASSTING-dependent induction of type I interferons. Immunity 2016;44:597-608. https://doi.org/10.1016/j.immuni.2016.02.004
- Doavi T, Mousavi SL, Kamali M, Amani J, Fasihi Ramandi M. Chitosan-based intranasal vaccine against Escherichia coli O157:H7. Iran Biomed J 2016;20:97-108.
피인용 문헌
- Demystifying particle-based oral vaccines vol.18, pp.10, 2018, https://doi.org/10.1080/17425247.2021.1946511